Pedrós Consuelo, Formiga Francesc, Corbella Xavier, Arnau Josep Maria
Clinical Pharmacology Department, Bellvitge University Hospital, c/ Feixa Llarga s/n, 08907, L'Hospitalet de Llobregat, Barcelona, Spain.
Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain.
Eur J Clin Pharmacol. 2016 Feb;72(2):219-26. doi: 10.1007/s00228-015-1974-0. Epub 2015 Nov 7.
To assess the prevalence of urgent hospitalization due to adverse drug reactions (ADRs) in patients aged ≥ 65 years, to compare the in-hospital mortality rates between patients admitted for ADRs and those admitted for other causes, and to describe the ADRs, the used and suspected drugs, and the drug-reaction associations.
A cross-sectional study was conducted by using the institutional database of the Pharmacovigilance Programme of Bellvitge University Hospital, a 750-bed tertiary care hospital, with information corresponding to a 7-year period. ADR-related admissions of patients aged ≥ 65 years prospectively identified through a systematic daily review of all admission diagnosis were reviewed.
ADRs were suspected to be the main reason for urgent admission in 1976 out of 60,263 patients aged ≥ 65 years (prevalence of ADR-related hospitalization 3.3 % [95 % CI 3.1-3.4 %]). The crude in-hospital mortality rate was 10.2 % in patients with ADR-related admission and 9 % in patients admitted for other causes (p = 0.077). Most patients (86 %) were exposed to polypharmacy, and a drug-drug interaction was suspected in 49 % of cases. The most frequent drug-reaction associations were acute renal failure related to renin-angiotensin system inhibitors, gastrointestinal bleeding caused by antithrombotics and/or non-steroidal anti-inflammatories, and intracranial bleeding induced by vitamin K antagonists.
One out of every 30 urgent admissions of patients aged ≥ 65 years is ADR-related. These ADRs can be as serious and life-threatening as any other acute pathology that merits urgent hospital admission. Most cases involve patients exposed to polypharmacy and result from well-known reactions of a few commonly used drugs.
评估65岁及以上患者因药物不良反应(ADR)导致紧急住院的患病率,比较因ADR入院患者与因其他原因入院患者的院内死亡率,并描述ADR、使用和怀疑的药物以及药物反应关联。
采用巴塞罗那大学医院药物警戒计划的机构数据库进行横断面研究,该医院是一家拥有750张床位的三级护理医院,数据涵盖7年时间。通过对所有入院诊断进行系统的每日审查,前瞻性地识别65岁及以上患者与ADR相关的入院情况并进行审查。
在60263名65岁及以上患者中,有1976例被怀疑ADR是紧急入院的主要原因(ADR相关住院患病率为3.3%[95%CI 3.1 - 3.4%])。因ADR入院患者的粗院内死亡率为10.2%,因其他原因入院患者为9%(p = 0.077)。大多数患者(86%)使用多种药物,49%的病例怀疑存在药物相互作用。最常见的药物反应关联是与肾素 - 血管紧张素系统抑制剂相关的急性肾衰竭、由抗血栓药和/或非甾体抗炎药引起的胃肠道出血以及维生素K拮抗剂诱发的颅内出血。
65岁及以上患者每30例紧急入院中有1例与ADR相关。这些ADR可能与任何其他需要紧急住院的急性病症一样严重并危及生命。大多数病例涉及使用多种药物的患者,且由少数常用药物的已知反应引起。